However, CD34+/CD38− stem cells and CD34+/CD38+ progenitor cells as well as chronic phase CML basophils expressed Met at low levels, and IL-3 stimulation did not induce Met expression on the surface of CD34+/CD38− stem cells or CML basophils. Here, MET is linked to chronic myelogenous leukemia, BCR-ABL1 positive.